Advanced search
Publication Cover
Postgraduate Medicine Volume 127, 2015 - Issue 3
Submit an article Journal homepage
481
Views
0
CrossRef citations to date
0
Altmetric
Clinical Feature

Review of empagliflozin monotherapy for previously untreated patients with type 2 diabetes mellitus: Comparison with sitagliptin

Original article: Roden M, Weng J, Eilbracht J, Delafont B, Kim G, Woerle HJ, Broedl UC, on behalf of the EMPA-REG MONO trial investigators. Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2013;1(3):208–19.

Susan CornellMidwestern University Chicago College of Pharmacy, Downers Grove, IL, USACorrespondence[email protected]
Pages 277-281 | Received 19 Dec 2014, Accepted 10 Feb 2015, Published online: 27 Feb 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.